Maternal and neonatal exposure to environmental tobacco smoke targets pro-inflammatory genes in neonatal arteries

Journal of Cardiovascular Translational Research

Volumn 3, Issue 6, 2010, Pages 696-703

  Villablanca, Amparo C ^a   Pinkerton, Kent E ^b   Rutledge, John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Genes; Inflammation; Macroarray; Monkey; Neonate; Smoking; Vascular

Indexed keywords

AUTACOID; MESSENGER RNA;

ANIMAL; ARTICLE; CAROTID ARTERY; DNA MICROARRAY; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GESTATIONAL AGE; IMMUNOLOGY; INFLAMMATION; MACACA MULATTA; METABOLISM; METHODOLOGY; NEWBORN; PASSIVE SMOKING; PREGNANCY; PRENATAL EXPOSURE; SMOKE; TIME; VASCULAR DISEASE; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CAROTID ARTERIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GESTATIONAL AGE; INFLAMMATION; INFLAMMATION MEDIATORS; MACACA MULATTA; MATERNAL EXPOSURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RNA, MESSENGER; SMOKE; TIME FACTORS; TOBACCO SMOKE POLLUTION; VASCULAR DISEASES;

EID: 79952791019     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-010-9226-2     Document Type: Article

References (41)

1. Barber, K., Mussin, E., & Taylor, D. K. (1996). Fetal exposure to involuntary maternal smoking and childhood respiratory disease. Annals of Allergy, Asthma & Immunology, 76(5), 427-430. (Pubitemid 26153154)
2. Dybing, E., & Sanner, T. (1999). Passive smoking, sudden infant death syndrome (SIDS) and childhood infections. Human & Experimental Toxicology, 18(4), 202-205. (Pubitemid 29187028)
3. Hanke, W., Sobala, W., & Kalinka, J. (2004). Environmental tobacco smoke exposure among pregnant women: impact on fetal biometry at 20-24 weeks of gestation and newborn child's birth weight. International Archives of Occupational and Environmental Health, 77(1), 47-52. (Pubitemid 38094421)
4. Hutchison, S. J., et al. (1998). In utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. Journal of the American College of Cardiology, 32(5), 1463-1467. (Pubitemid 28522411)
5. Ji, C. M., et al. (1998). Maternal exposure to environmental tobacco smoke alters Clara cell secretory protein expression in fetal rat lung. The American Journal of Physiology, 275(5 Pt 1), L870-L876.
6. Joad, J. P., et al. (1999). Perinatal exposure to aged and diluted sidestream cigarette smoke produces airway hyperresponsiveness in older rats. Toxicology and Applied Pharmacology, 155(3), 253-260. (Pubitemid 29153373)
7. Lee, C. Z., et al. (2000). Effect of in utero and postnatal exposure to environmental tobacco smoke on the developmental expression of pulmonary cytochrome P450 monooxygenases. Journal of Biochemical and Molecular Toxicology, 14(3), 121-130.
8. Milner, A. D., et al. (1999). Effects of smoking in pregnancy on neonatal lung function. Archives of Disease in Childhood. Fetal and Neonatal Edition, 80(1), F8-F14.
9. Nelson, E., et al. (1999). Maternal passive smoking during pregnancy and foetal developmental toxicity. Part 2: histological changes. Human & Experimental Toxicology, 18(4), 257-264. (Pubitemid 29187038)
10. Obwegeser, R., et al. (1999). Maternal cigarette smoking increases F2-isoprostanes and reduces prostacyclin and nitric oxide in umbilical vessels. Prostaglandins & Other Lipid Mediators, 57 (4), 269-279.
11. Oncken, C. A., et al. (2003). Effect of maternal smoking on fetal catecholamine concentrations at birth. Pediatric Research, 53(1), 119-124. (Pubitemid 36033991)
12. Windsor, R. (2003). Smoking cessation or reduction in pregnancy treatment methods: a meta-evaluation of the impact of dissemination. The American Journal of the Medical Sciences, 326(4), 216-222.
13. Matturri, L., et al. (2003). Intimal preatherosclerotic thickening of the coronary arteries in human fetuses of smoker mothers. Journal of Thrombosis and Haemostasis, 1(10), 2234-2238.
14. Berenson, G. S., & Srinivasan, S. R. (1999). Prevention of atherosclerosis in childhood. Lancet, 354(9186), 1223-1224. (Pubitemid 29469346)
15. Raitakari, O. T., et al. (2003). Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Jama, 290(17), 2277-2283. (Pubitemid 37430560)
16. Knoflach, M., et al. (2003). Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation, 108(9), 1064-1069. (Pubitemid 37071515)
17. Williams, C. L., et al. (2002). Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 106(1), 143-160. (Pubitemid 34747456)
18. Zieske, A. W., Malcom, G. T., & Strong, J. P. (2002). Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatric Pathology & Molecular Medicine, 21 (2), 213-237.
19. Pope, C. A., 3rd, et al. (2004). Cardiovascular mortality and longterm exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation, 109(1), 71-77.
20. Mullick, A. E., et al. (2002). Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury. American Journal of Physiology. Heart and Circulatory Physiology, 283(2), H591-H597. (Pubitemid 34790853)
21. Roberts, K. A., et al. (1996). Effect of environmental tobacco smoke on LDL accumulation in the artery wall. Circulation, 94 (9), 2248-2253. (Pubitemid 26360521)
22. Taub, D. D., & Oppenheim, J. J. (1994). Chemokines, inflammation and the immune system. Therapeutic Immunology, 1(4), 229-246. (Pubitemid 24278716)
23. Ross, R. (1999). Atherosclerosis is an inflammatory disease. American Heart Journal, 138(5 Pt 2), S419-S420.
24. Ross, R., & Glomset, J. A. (1973). Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science, 180(93), 1332-1339.
25. Libby, P. (2006). Inflammation and cardiovascular disease mechanisms. The American Journal of Clinical Nutrition, 83(2),456S-460S.
26. Vasankari, T., et al. (2001). Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy. Atherosclerosis, 155(2), 403-412.
27. Weber, C., Schober, A., & Zernecke, A. (2004). Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(11), 1997-2008. (Pubitemid 39482421)
28. Ramos, M. A., et al. (1998). Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arteriosclerosis, Thrombosis, and Vascular Biology, 18(7), 1188-1196. (Pubitemid 28323605)
29. Appay, V., & Rowland-Jones, S. L. (2001). RANTES: a versatile and controversial chemokine. Trends in Immunology, 22(2), 83-87. (Pubitemid 32667526)
30. Conti, P., & DiGioacchino, M. (2001). MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy and Asthma Proceedings, 22(3), 133-137.
31. Lloyd, C. M., et al. (1997). Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. Journal of Leukocyte Biology, 62(5), 676-680. (Pubitemid 27519779)
32. Krishnaswamy, G., et al. (1999). Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. Journal of Interferon & Cytokine Research, 19(2), 91-104. (Pubitemid 29109625)
33. Galkina, E., & Ley, K. (2007). Vascular adhesion molecules in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(11), 2292-2301. (Pubitemid 350203942)
34. Springer, T. A. (1990). Adhesion receptors of the immune system. Nature, 346(6283), 425-434.
35. Watanabe, T., & Fan, J. (1998). Atherosclerosis and inflammation mononuclear cell recruitment and adhesion molecules with reference to the implication of ICAM-1/LFA-1 pathway in atherogenesis. International Journal of Cardiology, Suppl 66(1), S45-S53. discussion S55.
36. Celletti, F. L., et al. (2001). Vascular endothelial growth factor enhances atherosclerotic plaque progression. Natural Medicines, 7 (4), 425-429. (Pubitemid 32298544)
37. Virmani, R., et al. (2005). Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(10), 2054-2061. (Pubitemid 41416300)
38. Burke, P. A., Lehmann-Bruinsma, K., & Powell, J. S. (1995). Vascular endothelial growth factor causes endothelial proliferation after vascular injury. Biochemical and Biophysical Research Communications, 207(1), 348-354.
39. Gill, M., et al. (2001). Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circulation Research, 88(2), 167-174. (Pubitemid 32147304)
40. Ray, P. S., & Fox, P. L. (2007). A post-transcriptional pathway represses monocyte VEGF-A expression and angiogenic activity. The EMBO Journal, 26 (14), 3360-3372.
41. Westbrook, D., Anderson, P., Pinkerton, K., & Ballinger, S. (2010). Perinatal tobacco smoke exposure increases vascular oxidative stress and mitochondrial damage in non-human primates. Cardiovascular Toxicology, 10(3), 216-226.